网络药理学和Fraxinus floribunda的分子对接:验证T2DM中的民族医学应用
Arunika Subba1, Rohit Rai1, Ranjan Kumar Prasad1
1Department of Botany, Sikkim Alpine University, Main Campus, Kamrang, Namchi, 737126 Sikkim India.
In silico pharmacology
|April 21, 2025
概括
弗拉克辛斯 (Fraxinus floribunda) 的化合物显示出对2型糖尿病 (T2DM) 管理的潜力. 计算分析证实了它们抑制MMP9的能力,这表明了糖尿病的新治疗途径.
科学领域:
- 计算化学和药理学计算化学和药理学
- 自然产品药物发现自然产品药物发现
- 代谢性疾病研究研究.
背景情况:
- 对于糖尿病的Fraxinus floribunda的民族医学用途是广泛的.
- 缺乏对其在2型糖尿病 (T2DM) 的治疗应用的现代科学验证.
- 需要新的治疗药物来有效管理T2DM.
研究的目的:
- 研究Fraxinus floribunda生物活性化合物在T2DM管理中的潜力.
- 通过网络药理学,分子对接和分子动力学模拟来验证民族医学要求.
- 确定T2DM治疗的关键化合物及其分子标.
主要方法:
- 从F. floribunda中鉴定了五种主要的生物活性化合物,基于药理动力学特性.
- 使用瑞士目标基因对目标基因的预测和蛋白质-蛋白质相互作用网络的构建.
- 分子对接和分子动力学 (MD) 模拟以评估与MMP9.9的结合亲和力和复杂稳定性.
主要成果:
- 网络药理学发现了143个节点和1300个边缘之间的显著相互作用.
- 奎尔塞丁,塔马里克塞丁和异姆尼丁对MMP9表现出强烈的结合亲和力,由MD模拟和MM-PBSA计算证实.
- 这些化合物显示出作为MMP9抑制剂的潜力,在T2DM途径中至关重要.
结论:
- Fraxinus floribunda 含有具有T2DM管理显著潜力的生物活性化合物.
- 该研究通过现代计算方法验证了传统的使用,强调MMP9抑制是关键机制.
- 建议进行进一步的研究和临床试验,以开发F. floribunda衍生治疗T2DM和代谢障碍的治疗方法.
关键词:
生物活性化合物 生物活性化合物弗拉克辛斯 (Fraxinus floribunda) 是一种花的植物.在MM-PBSASA中使用.分子对接是分子对接.分子动力学模拟模型网络药理学 网络药理学二型糖尿病 (T2DM) 是一种糖尿病.更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
1.8K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
468
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Ligand Binding and Linkage
2.9K
2.9K
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
The Equilibrium Binding Constant and Binding Strength
12.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.7K
